These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 33758841)

  • 1. A novel soluble ACE2 protein totally protects from lethal disease caused by SARS-CoV-2 infection.
    Hassler L; Wysocki J; Gelarden I; Tomatsidou A; Gula H; Nicoleascu V; Randall G; Henkin J; Yeldandi A; Batlle D
    bioRxiv; 2021 Mar; ():. PubMed ID: 33758841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Soluble ACE2 Protein Provides Lung and Kidney Protection in Mice Susceptible to Lethal SARS-CoV-2 Infection.
    Hassler L; Wysocki J; Gelarden I; Sharma I; Tomatsidou A; Ye M; Gula H; Nicoleascu V; Randall G; Pshenychnyi S; Khurram N; Kanwar Y; Missiakas D; Henkin J; Yeldandi A; Batlle D
    J Am Soc Nephrol; 2022 Jul; 33(7):1293-1307. PubMed ID: 35236774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superiority of intranasal over systemic administration of bioengineered soluble ACE2 for survival and brain protection against SARS-CoV-2 infection.
    Hassler L; Wysocki J; Ahrendsen JT; Ye M; Gelarden I; Nicolaescu V; Tomatsidou A; Gula H; Cianfarini C; Khurram N; Kanwar Y; Singer BD; Randall G; Missiakas D; Henkin J; Batlle D
    bioRxiv; 2022 Dec; ():. PubMed ID: 36523403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal soluble ACE2 improves survival and prevents brain SARS-CoV-2 infection.
    Hassler L; Wysocki J; Ahrendsen JT; Ye M; Gelarden I; Nicolaescu V; Tomatsidou A; Gula H; Cianfarini C; Forster P; Khurram N; Singer BD; Randall G; Missiakas D; Henkin J; Batlle D
    Life Sci Alliance; 2023 Jul; 6(7):. PubMed ID: 37041017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel Soluble ACE2 Variant with Prolonged Duration of Action Neutralizes SARS-CoV-2 Infection in Human Kidney Organoids.
    Wysocki J; Ye M; Hassler L; Gupta AK; Wang Y; Nicoleascu V; Randall G; Wertheim JA; Batlle D
    J Am Soc Nephrol; 2021 Apr; 32(4):795-803. PubMed ID: 33526471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of SARS-CoV-2 and Other Coronavirus With ACE (Angiotensin-Converting Enzyme)-2 as Their Main Receptor: Therapeutic Implications.
    Davidson AM; Wysocki J; Batlle D
    Hypertension; 2020 Nov; 76(5):1339-1349. PubMed ID: 32851855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Binding to ACE2 Receptors from Human, Pets, Farm Animals, and Putative Intermediate Hosts.
    Zhai X; Sun J; Yan Z; Zhang J; Zhao J; Zhao Z; Gao Q; He WT; Veit M; Su S
    J Virol; 2020 Jul; 94(15):. PubMed ID: 32404529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pivotal link between ACE2 deficiency and SARS-CoV-2 infection.
    Verdecchia P; Cavallini C; Spanevello A; Angeli F
    Eur J Intern Med; 2020 Jun; 76():14-20. PubMed ID: 32336612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19.
    Zhang S; Liu Y; Wang X; Yang L; Li H; Wang Y; Liu M; Zhao X; Xie Y; Yang Y; Zhang S; Fan Z; Dong J; Yuan Z; Ding Z; Zhang Y; Hu L
    J Hematol Oncol; 2020 Sep; 13(1):120. PubMed ID: 32887634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy.
    Datta PK; Liu F; Fischer T; Rappaport J; Qin X
    Theranostics; 2020; 10(16):7448-7464. PubMed ID: 32642005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice.
    Bao L; Deng W; Huang B; Gao H; Liu J; Ren L; Wei Q; Yu P; Xu Y; Qi F; Qu Y; Li F; Lv Q; Wang W; Xue J; Gong S; Liu M; Wang G; Wang S; Song Z; Zhao L; Liu P; Zhao L; Ye F; Wang H; Zhou W; Zhu N; Zhen W; Yu H; Zhang X; Guo L; Chen L; Wang C; Wang Y; Wang X; Xiao Y; Sun Q; Liu H; Zhu F; Ma C; Yan L; Yang M; Han J; Xu W; Tan W; Peng X; Jin Q; Wu G; Qin C
    Nature; 2020 Jul; 583(7818):830-833. PubMed ID: 32380511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human angiotensin-converting enzyme 2 transgenic mice infected with SARS-CoV-2 develop severe and fatal respiratory disease.
    Golden JW; Cline CR; Zeng X; Garrison AR; Carey BD; Mucker EM; White LE; Shamblin JD; Brocato RL; Liu J; Babka AM; Rauch HB; Smith JM; Hollidge BS; Fitzpatrick C; Badger CV; Hooper JW
    JCI Insight; 2020 Oct; 5(19):. PubMed ID: 32841215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin-converting enzyme 2 (ACE2) receptor and SARS-CoV-2: Potential therapeutic targeting.
    Sharifkashani S; Bafrani MA; Khaboushan AS; Pirzadeh M; Kheirandish A; Yavarpour Bali H; Hessami A; Saghazadeh A; Rezaei N
    Eur J Pharmacol; 2020 Oct; 884():173455. PubMed ID: 32745604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 preclinical models: human angiotensin-converting enzyme 2 transgenic mice.
    Lutz C; Maher L; Lee C; Kang W
    Hum Genomics; 2020 Jun; 14(1):20. PubMed ID: 32498696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role and mechanism of angiotensin-converting enzyme 2 in acute lung injury in coronavirus disease 2019.
    Liu MY; Zheng B; Zhang Y; Li JP
    Chronic Dis Transl Med; 2020 Jun; 6(2):98-105. PubMed ID: 32550040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Broad and Differential Animal Angiotensin-Converting Enzyme 2 Receptor Usage by SARS-CoV-2.
    Zhao X; Chen D; Szabla R; Zheng M; Li G; Du P; Zheng S; Li X; Song C; Li R; Guo JT; Junop M; Zeng H; Lin H
    J Virol; 2020 Aug; 94(18):. PubMed ID: 32661139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant ACE2 Expression Is Required for SARS-CoV-2 To Infect Primary Human Endothelial Cells and Induce Inflammatory and Procoagulative Responses.
    Nascimento Conde J; Schutt WR; Gorbunova EE; Mackow ER
    mBio; 2020 Dec; 11(6):. PubMed ID: 33310781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insights on SARS-CoV-2 Molecular Interactions With the Renin-Angiotensin System.
    Costa LB; Perez LG; Palmeira VA; Macedo E Cordeiro T; Ribeiro VT; Lanza K; Simões E Silva AC
    Front Cell Dev Biol; 2020; 8():559841. PubMed ID: 33042994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lethality of SARS-CoV-2 infection in K18 human angiotensin-converting enzyme 2 transgenic mice.
    Oladunni FS; Park JG; Pino PA; Gonzalez O; Akhter A; Allué-Guardia A; Olmo-Fontánez A; Gautam S; Garcia-Vilanova A; Ye C; Chiem K; Headley C; Dwivedi V; Parodi LM; Alfson KJ; Staples HM; Schami A; Garcia JI; Whigham A; Platt RN; Gazi M; Martinez J; Chuba C; Earley S; Rodriguez OH; Mdaki SD; Kavelish KN; Escalona R; Hallam CRA; Christie C; Patterson JL; Anderson TJC; Carrion R; Dick EJ; Hall-Ursone S; Schlesinger LS; Alvarez X; Kaushal D; Giavedoni LD; Turner J; Martinez-Sobrido L; Torrelles JB
    Nat Commun; 2020 Nov; 11(1):6122. PubMed ID: 33257679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of Plant-Produced Recombinant ACE2-Fc Fusion Protein as a Potential Therapeutic Agent Against SARS-CoV-2.
    Siriwattananon K; Manopwisedjaroen S; Kanjanasirirat P; Budi Purwono P; Rattanapisit K; Shanmugaraj B; Smith DR; Borwornpinyo S; Thitithanyanont A; Phoolcharoen W
    Front Plant Sci; 2020; 11():604663. PubMed ID: 33584747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.